Cargando…

Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract

Spirulina platensis contains several compounds showing nutritional and therapeutic benefits. Recently, a series of peptides able to reduce the blood pressure level and to enhance the endothelial vasorelaxation was isolated from the hydrolyzed highly water-soluble Spirulina extract (HSE). However, HS...

Descripción completa

Detalles Bibliográficos
Autores principales: Aquino, Rita P., Auriemma, Giulia, Conte, Giulio M., Esposito, Tiziana, Sommella, Eduardo, Campiglia, Pietro, Sansone, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248919/
https://www.ncbi.nlm.nih.gov/pubmed/32365705
http://dx.doi.org/10.3390/molecules25092086
_version_ 1783538482524717056
author Aquino, Rita P.
Auriemma, Giulia
Conte, Giulio M.
Esposito, Tiziana
Sommella, Eduardo
Campiglia, Pietro
Sansone, Francesca
author_facet Aquino, Rita P.
Auriemma, Giulia
Conte, Giulio M.
Esposito, Tiziana
Sommella, Eduardo
Campiglia, Pietro
Sansone, Francesca
author_sort Aquino, Rita P.
collection PubMed
description Spirulina platensis contains several compounds showing nutritional and therapeutic benefits. Recently, a series of peptides able to reduce the blood pressure level and to enhance the endothelial vasorelaxation was isolated from the hydrolyzed highly water-soluble Spirulina extract (HSE). However, HSE shows critical organoleptic characteristics also having poor intestinal permeability, limiting absorption when orally delivered. This research aims to overcome the critical issues through the encapsulation of HSE in Chitosan/Mannitol—(CM)-based microparticles by spray drying. The produced powders (CM-HSE) showed good process yield (≈70%) and encapsulation efficiency (≈100%) also having good derived flow properties as well as stability up to six months storage. The microparticles constituting the spray-dried powder resulted in an amorphous micrometric state (d(50) ≈ 14 µm) able to retain dark colour and unpleasant smell of raw HSE. Moreover, the in vitro permeation study by Franz cell indicated that the engineered microparticles are able to enhance the permeation of HSE through an intestinal biomimetic barrier (551.13 μg/cm(2) CM-HSE vs. 315.46 μg/cm(2) HSE at 270 min).
format Online
Article
Text
id pubmed-7248919
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72489192020-06-10 Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract Aquino, Rita P. Auriemma, Giulia Conte, Giulio M. Esposito, Tiziana Sommella, Eduardo Campiglia, Pietro Sansone, Francesca Molecules Article Spirulina platensis contains several compounds showing nutritional and therapeutic benefits. Recently, a series of peptides able to reduce the blood pressure level and to enhance the endothelial vasorelaxation was isolated from the hydrolyzed highly water-soluble Spirulina extract (HSE). However, HSE shows critical organoleptic characteristics also having poor intestinal permeability, limiting absorption when orally delivered. This research aims to overcome the critical issues through the encapsulation of HSE in Chitosan/Mannitol—(CM)-based microparticles by spray drying. The produced powders (CM-HSE) showed good process yield (≈70%) and encapsulation efficiency (≈100%) also having good derived flow properties as well as stability up to six months storage. The microparticles constituting the spray-dried powder resulted in an amorphous micrometric state (d(50) ≈ 14 µm) able to retain dark colour and unpleasant smell of raw HSE. Moreover, the in vitro permeation study by Franz cell indicated that the engineered microparticles are able to enhance the permeation of HSE through an intestinal biomimetic barrier (551.13 μg/cm(2) CM-HSE vs. 315.46 μg/cm(2) HSE at 270 min). MDPI 2020-04-29 /pmc/articles/PMC7248919/ /pubmed/32365705 http://dx.doi.org/10.3390/molecules25092086 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Aquino, Rita P.
Auriemma, Giulia
Conte, Giulio M.
Esposito, Tiziana
Sommella, Eduardo
Campiglia, Pietro
Sansone, Francesca
Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract
title Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract
title_full Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract
title_fullStr Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract
title_full_unstemmed Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract
title_short Development of Chitosan/Mannitol Microparticles as Delivery System for the Oral Administration of a Spirulina Bioactive Peptide Extract
title_sort development of chitosan/mannitol microparticles as delivery system for the oral administration of a spirulina bioactive peptide extract
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248919/
https://www.ncbi.nlm.nih.gov/pubmed/32365705
http://dx.doi.org/10.3390/molecules25092086
work_keys_str_mv AT aquinoritap developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract
AT auriemmagiulia developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract
AT contegiuliom developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract
AT espositotiziana developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract
AT sommellaeduardo developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract
AT campigliapietro developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract
AT sansonefrancesca developmentofchitosanmannitolmicroparticlesasdeliverysystemfortheoraladministrationofaspirulinabioactivepeptideextract